JP2018502577A5 - - Google Patents

Download PDF

Info

Publication number
JP2018502577A5
JP2018502577A5 JP2017536325A JP2017536325A JP2018502577A5 JP 2018502577 A5 JP2018502577 A5 JP 2018502577A5 JP 2017536325 A JP2017536325 A JP 2017536325A JP 2017536325 A JP2017536325 A JP 2017536325A JP 2018502577 A5 JP2018502577 A5 JP 2018502577A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
atcc
variant
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017536325A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018502577A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/012603 external-priority patent/WO2016112261A2/en
Publication of JP2018502577A publication Critical patent/JP2018502577A/ja
Publication of JP2018502577A5 publication Critical patent/JP2018502577A5/ja
Pending legal-status Critical Current

Links

JP2017536325A 2015-01-09 2016-01-08 ヒトdpp−4を検出するためのアッセイ Pending JP2018502577A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562101697P 2015-01-09 2015-01-09
US62/101,697 2015-01-09
PCT/US2016/012603 WO2016112261A2 (en) 2015-01-09 2016-01-08 Assay to detect human dpp-4

Publications (2)

Publication Number Publication Date
JP2018502577A JP2018502577A (ja) 2018-02-01
JP2018502577A5 true JP2018502577A5 (https=) 2019-02-14

Family

ID=56356576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017536325A Pending JP2018502577A (ja) 2015-01-09 2016-01-08 ヒトdpp−4を検出するためのアッセイ

Country Status (14)

Country Link
US (2) US10351630B2 (https=)
EP (1) EP3242686B1 (https=)
JP (1) JP2018502577A (https=)
KR (1) KR20170098941A (https=)
CN (1) CN107206079A (https=)
AU (1) AU2016205188A1 (https=)
BR (1) BR112017011724A2 (https=)
CA (1) CA2970540A1 (https=)
HK (2) HK1244444A1 (https=)
IL (1) IL252528A0 (https=)
MX (1) MX2017008748A (https=)
RU (1) RU2017127182A (https=)
SG (1) SG11201705598VA (https=)
WO (1) WO2016112261A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118359716A (zh) * 2023-01-18 2024-07-19 江苏众红生物工程创药研究院有限公司 抗cd26抗体及其用途
CN118791612A (zh) * 2023-04-14 2024-10-18 江苏众红生物工程创药研究院有限公司 靶向cd26的抗原结合蛋白及其药物应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681718A (en) 1986-03-14 1997-10-28 Celltech Limited Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
US7115555B2 (en) * 1998-07-09 2006-10-03 Baylor College Of Medicine Hypohidrotic ectodermal dysplasia genes and proteins
US6573096B1 (en) * 2000-04-01 2003-06-03 The Research Foundation At State University Of New York Compositions and methods for inhibition of cancer invasion and angiogenesis
EP1392361A4 (en) * 2001-05-11 2009-08-05 Univ Texas ANTI-CD26 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CD26 EXPRESSIVE CELLS
GB0216648D0 (en) 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
EP1631680A2 (en) 2003-05-21 2006-03-08 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
GB0407315D0 (en) 2003-07-15 2004-05-05 Cambridge Antibody Tech Human antibody molecules
WO2005075514A2 (en) 2004-03-10 2005-08-18 Lonza Ltd. Method for producing antibodies
EP1907425B1 (en) * 2005-07-22 2014-01-08 Y's Therapeutics Co., Ltd. Anti-cd26 antibodies and methods of use thereof
WO2008091814A2 (en) 2007-01-22 2008-07-31 Wyeth Assessment of asthma and allergen-dependent gene expression
EP2631302A3 (en) 2008-03-31 2014-01-08 Genentech, Inc. Compositions and methods for treating and diagnosing asthma
US20100221752A2 (en) 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
MX2013004212A (es) 2010-10-15 2013-09-02 Medimmune Ltd Terapias para mejorar la funcion pulmonar.
TWI732259B (zh) 2010-12-16 2021-07-01 美商建南德克公司 關於th2抑制作用之診斷及治療
EP2710370A4 (en) 2011-05-18 2015-01-07 Medimmune Llc METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS
US20160363591A1 (en) 2014-01-27 2016-12-15 Medimmune, Llc Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung

Similar Documents

Publication Publication Date Title
US11421035B2 (en) Stable antibody variable domain framework combinations and methods of use thereof
JP2021525546A5 (https=)
JP2010502183A5 (https=)
HRP20201375T1 (hr) ANTI-BCMA ANTITIJELA, BISPECIFIČNI ANTIGEN VEŽUĆE MOLEKULE KOJE SE VEŽU ZA BCMA i CD3, I NJIHOVE UPOTREBE
IL273196B1 (en) Claudin 6 antibodies and methods of cancer treatment
HRP20200390T1 (hr) Monoklonska antitijela protiv humanog antigena starenja b stanica (bcma)
RU2018102606A (ru) Молекулы, связывающиеся с psl pseudomonas, и пути их применения
JP2020534830A5 (https=)
JP2013535191A5 (https=)
HRP20191697T1 (hr) Vezujuće molekule za bcma i cd3
JP2017506064A5 (https=)
JP2012525829A5 (https=)
JP2017504578A5 (https=)
CN115605511A (zh) 抗tigit的抗体、其制备方法和应用
CN106432495A (zh) 抗肿瘤抗原抗体及其使用方法
JP2020524510A5 (https=)
JP2014529590A5 (https=)
JP2015529202A5 (https=)
JP2017524362A5 (https=)
RU2016135418A (ru) Новый анализ для детектирования периостина человека
AU2021280232B2 (en) Anti-PD-1 antibodies
JP2020532572A5 (https=)
US20170320966A1 (en) Humanized monoclonal antibody and uses thereof
JP2017507322A5 (https=)
JP2019504014A5 (https=)